ATE353103T1 - Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen - Google Patents

Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen

Info

Publication number
ATE353103T1
ATE353103T1 AT95925024T AT95925024T ATE353103T1 AT E353103 T1 ATE353103 T1 AT E353103T1 AT 95925024 T AT95925024 T AT 95925024T AT 95925024 T AT95925024 T AT 95925024T AT E353103 T1 ATE353103 T1 AT E353103T1
Authority
AT
Austria
Prior art keywords
pct
human kappa
opiatic
receptor
nucleic acids
Prior art date
Application number
AT95925024T
Other languages
English (en)
Inventor
Brigitte Kieffer
Frederic Simonin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE353103T1 publication Critical patent/ATE353103T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT95925024T 1994-07-11 1995-07-07 Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen ATE353103T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408531A FR2722209B1 (fr) 1994-07-11 1994-07-11 Recepteur opioide kappa humain, acides nucleiques et utilisations

Publications (1)

Publication Number Publication Date
ATE353103T1 true ATE353103T1 (de) 2007-02-15

Family

ID=9465221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95925024T ATE353103T1 (de) 1994-07-11 1995-07-07 Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen

Country Status (9)

Country Link
US (1) US6146835A (de)
EP (1) EP0804574B1 (de)
JP (1) JP3643598B2 (de)
AT (1) ATE353103T1 (de)
CA (1) CA2194768A1 (de)
DE (1) DE69535380T2 (de)
ES (1) ES2281073T3 (de)
FR (1) FR2722209B1 (de)
WO (1) WO1996001898A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750825B1 (fr) * 1996-07-15 2002-08-23 Centre Nat Rech Scient Animal transgenique non humain dans lequel l'expression de l'un au moins des genes codant pour les recepteurs aux opiaces est modifiee
SE522192C2 (sv) * 2000-05-17 2004-01-20 Vaegverket Produktion Krockdämpande anordning för fordon samt metod
WO2005015242A1 (en) * 2003-08-06 2005-02-17 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor kappa 1 (opkr1)
US7874572B2 (en) * 2005-01-10 2011-01-25 Energy Absorption Systems, Inc. Towable impact attenuator

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096513A (en) * 1993-05-20 2000-08-01 Arch Development Corporation Polynucleotides encoding KAPPA opiod receptors

Also Published As

Publication number Publication date
FR2722209B1 (fr) 1996-08-14
ES2281073T3 (es) 2007-09-16
US6146835A (en) 2000-11-14
FR2722209A1 (fr) 1996-01-12
WO1996001898A1 (fr) 1996-01-25
EP0804574A1 (de) 1997-11-05
JPH10507904A (ja) 1998-08-04
EP0804574B1 (de) 2007-01-31
DE69535380T2 (de) 2007-11-08
JP3643598B2 (ja) 2005-04-27
CA2194768A1 (fr) 1996-01-25
DE69535380D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
DE69732871D1 (de) Basisches Protein Zusammensetzung, basisches Peptid Zusammensetzung und deren Verwendung
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
DE69839566D1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
DE69520088D1 (de) Interferon-gamma-induzierendes Polypeptid monoklonal Antikörper, und Zusammensetzung für Interferon-gamma gebunden Krankheiten
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
DE69938786D1 (de) Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
DE69825625D1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
ATE360695T1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
ATE299182T1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
DK0745122T3 (da) Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf
ATE353103T1 (de) Humaner kappa opiatrezeptor, nukleinsäuren und ihre verwendungen
DE69704269D1 (de) Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung
EA200000270A1 (ru) КОМПОЗИЦИИ ДЛЯ ГЕНОТЕРАПИИ С ИСПОЛЬЗОВАНИЕМ ГЕНОВ, КОДИРУЮЩИХ СЕКРЕТИРУЕМЫЕ БЕЛКИ, ТАКИЕ КАК β-ИНТЕРФЕРОН, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
CA2139430A1 (fr) Polypeptides ayant une activite de recepteur serotoninergique (5ht5a), acides nucleiques codant pour ces polypeptides et utilisations
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
ATE294861T1 (de) Polypeptide mit opioider rezeptor-aktvität, für sie kodierende nukleinsäuren und ihre verwendungen
ZA966489B (en) New protein human MP52 Arg.
DE59814002D1 (de) Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum
TR199802300T2 (xx) �nsan G proteini �3 alt-birimindeki bir gendeki genetik d�n���m�n hastal�klar�n te�hisi i�in kullan�lmas�.
DE69821919D1 (de) Fischprotein, dessen gen, reagenzien zur induktion von apoptose, und antikrebsmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties